The Procter & Gamble Company (NYSE:PG) Shares Sold by Borer Denton & Associates Inc.

Borer Denton & Associates Inc. decreased its holdings in The Procter & Gamble Company (NYSE:PG) by 1.4% in the third quarter, Holdings Channel reports. The firm owned 5,113 shares of the company’s stock after selling 75 shares during the period. Borer Denton & Associates Inc.’s holdings in Procter & Gamble were worth $886,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in PG. Acorn Creek Capital LLC lifted its holdings in Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock worth $376,000 after buying an additional 59 shares during the last quarter. Patrick M Sweeney & Associates Inc. raised its position in shares of Procter & Gamble by 1.1% during the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock worth $963,000 after acquiring an additional 59 shares in the last quarter. Hudson Value Partners LLC lifted its stake in Procter & Gamble by 4.1% during the second quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock worth $250,000 after purchasing an additional 60 shares during the last quarter. Traveka Wealth LLC boosted its holdings in Procter & Gamble by 1.7% in the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after purchasing an additional 60 shares in the last quarter. Finally, Fiduciary Alliance LLC increased its stake in Procter & Gamble by 2.8% in the second quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock valued at $371,000 after purchasing an additional 61 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, insider Susan Street Whaley sold 634 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the transaction, the insider now owns 19,341 shares in the company, valued at $3,319,882.65. This trade represents a 3.17 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Andre Schulten sold 13,041 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now directly owns 37,208 shares in the company, valued at approximately $6,325,360. The trade was a 25.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 160,693 shares of company stock worth $27,311,345 in the last 90 days. 0.18% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have recently weighed in on PG. Dbs Bank downgraded shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Piper Sandler initiated coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research report on Thursday, August 29th. Wells Fargo & Company upped their target price on Procter & Gamble from $188.00 to $190.00 and gave the company an “overweight” rating in a research report on Friday. Finally, Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research report on Monday, September 30th. Nine equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $178.00.

Procter & Gamble Trading Up 2.0 %

NYSE PG opened at $176.28 on Friday. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $415.15 billion, a P/E ratio of 30.39, a P/E/G ratio of 3.74 and a beta of 0.42. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94. The firm has a 50-day moving average price of $170.04 and a 200 day moving average price of $168.64.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same period in the prior year, the business posted $1.83 EPS. The company’s revenue for the quarter was down .6% on a year-over-year basis. Equities research analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.28%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.